Earnings Feed
Start Free
Home/Filings/4/0001654954-19-000380
4//SEC Filing

Gelbfish Gary A. 4

Accession 0001654954-19-000380

CIK 0001410098other
View on SEC.govCompany Profile

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:13 PM ET

Size

13.2 KB

Accession

0001654954-19-000380

Insider Transaction Report

Form 4
Period: 2019-01-10
CorMedix Inc.CRMD
Gelbfish Gary A.
Director
Transactions
  • Award

    Restricted Stock Units

    2019-01-10+12,500→ 2,654,871 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2019-01-10+75,000→ 75,000 total
    Exercise: $1.66Exp: 2029-01-10→ Common Stock (75,000 underlying)
Holdings

  • Stock Option (Right to Buy Common Stock)

    Exercise: $0.57Exp: 2028-02-16→ Common Stock, $0.001 par value per share (40,000 underlying)
    40,000

  • Stock Option (Right to Buy Common Stock)

    Exercise: $0.37Exp: 2027-08-03→ Common Stock, $0.001 par value per share (75,000 underlying)
    75,000

  • Common Stock

    (indirect: By Foundation)
    14,000

  • Series C-3 Non-Voting Convertible Preferred Stock

    From: 2014-01-08→ Common Stock, $0.001 par value per share (500,000 underlying)
    500,000

  • Warrant (Right to Purchase Common Stock)

    Exercise: $0.90From: 2015-01-08Exp: 2020-01-01→ Common Stock, $0.001 par value per share (250,000 underlying)
    250,000
Footnotes (6)
  • [F1]These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board.
  • [F2]Held by Landmark Foundation, of which Dr. Gelbfish and his wife are trustees.
  • [F3]These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  • [F4]These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  • [F5]These options vest as follows: 1/3 on August 3, 2017, an additional 1/3 on August 3, 2018, and the remaining 1/3 on August 3, 2019.
  • [F6]The conversion ratio is equal to the stated value of $10.00 divided by the conversion price of $1.00. The Series C-3 Non-Voting Convertible Preferred Stock is perpetual.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

→
Entity typeother

Related Parties

1
  • filerCIK 0001488011

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:13 PM ET
Size
13.2 KB
View on SEC.gov